AI Article Synopsis

Article Abstract

We present a rare case of histologically proven neurofibromatosis of the liver, hepatic hilum, retroperitoneum, and mesentery. An adult male who had been diagnosed with neurofibromatosis (NF) type 1 underwent a computed tomography (CT) scan for abdominal pain and vomiting. The CT scan showed a large low-attenuating lesion in the region of porta hepatis which was infiltrating along portal tracts into the liver, encasing the major vessels, and extending into the retroperitoneum and mesentery. Based on the radiological findings, a differential diagnosis of plexiform neurofibroma was given, although sarcomatous transformation could not have been entirely excluded from imaging alone. The tumor was subsequently biopsied, and the histopathological analysis confirmed the diagnosis of neurofibroma. This case highlights the importance and diagnostic dilemmas in the presence of this tumor at atypical locations in this disease spectrum.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5957520PMC
http://dx.doi.org/10.7759/cureus.2248DOI Listing

Publication Analysis

Top Keywords

retroperitoneum mesentery
8
hepatic periportal
4
periportal retroperitoneal
4
retroperitoneal mesenteric
4
mesenteric neurofibromatosis
4
neurofibromatosis von
4
von recklinghausen's
4
recklinghausen's disease
4
disease rare
4
rare case
4

Similar Publications

Lymphangioleiomyomatosis (LAM) is a rare, low-grade malignant condition that typically affects women of childbearing age and primarily involves the lungs. While cases involving males and affecting the gastrointestinal tract are exceedingly uncommon. This report discusses an unusual case of abdominal LAM in a male patient with gastrointestinal hemorrhage.

View Article and Find Full Text PDF
Article Synopsis
  • Liposarcoma of the uterine corpus is an extremely rare tumor with distinctive characteristics and treatment difficulties, as shown in a case study of a 57-year-old woman.
  • The patient initially had surgery and chemotherapy after presenting with severe abdominal issues, but faced multiple recurrences over the following years, including a more aggressive form of the tumor.
  • This case emphasizes the need for careful monitoring and individualized treatment plans to tackle the aggressive behavior of recurrent liposarcoma, particularly when it transforms into a dedifferentiated form.
View Article and Find Full Text PDF
Article Synopsis
  • - Dedifferentiated liposarcoma (DDL) is a rare and aggressive subtype typically found in the retroperitoneum, with challenging diagnostics, especially when it occurs in the mesentery as documented in very few cases.
  • - A 76-year-old woman was discovered to have a large mesenteric mass incidentally while being treated for pneumonia, leading to surgery where a tumor adherent to the intestine was removed and identified as intermediate-grade DDL.
  • - The case emphasizes the need to include mesenteric DDL in the differential diagnosis of large abdominal masses, highlighting that complete surgical resection is crucial for treatment, alongside regular follow-ups due to its aggressive nature.
View Article and Find Full Text PDF
Article Synopsis
  • * A single-port system was utilized for dissection around key anatomical landmarks, including Toldt’s and Gerota’s fascia, which facilitated access to the ileocolic vessels and lymph nodes while minimizing complications associated with past surgical adhesions.
  • * The operation lasted 240 minutes with minimal blood loss and low postoperative pain, indicating that this approach is safe and effective, allowing for successful treatment of cecal colon cancer and ensuring a manageable recovery time of 7 days
View Article and Find Full Text PDF
Article Synopsis
  • Current treatments for oligometastatic non-small cell lung cancer (NSCLC) mainly involve systemic chemotherapy and immune checkpoint inhibitors, but there's a need for better methods due to common recurrences.* -
  • The first case using the Ethos OART platform for delivering targeted radiotherapy was presented, involving a 67-year-old man with stage IV NSCLC and multiple metastatic sites.* -
  • The treatment utilized advanced planning techniques and adaptive strategies, resulting in over 80% tumor shrinkage and highlighting the potential benefits of this approach, though further research is necessary to establish its safety and efficacy.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!